Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection
- PMID: 29501487
- DOI: 10.1016/j.humpath.2018.02.016
Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection
Abstract
Acute T cell-mediated rejection (TCMR) is an important cause of renal allograft loss. The Banff classification for tubulointerstitial (type I) rejection is based on the extent of both interstitial inflammation and tubulitis. Lymphocytes may also be present between parietal epithelial cells and Bowman capsules in this setting, which we have termed "capsulitis." We conducted this study to determine the clinical significance of capsulitis. We identified 42 patients from the pathology archives at The University of Chicago with isolated Banff type I TCMR from 2010 to 2015. Patient demographic data, Banff classification, and graft outcome measurements were compared between capsulitis and noncapsulitis groups using Mann-Whitney U test. Capsulitis was present in 26 (62%) and was more frequently seen in Banff IB than in IA TCMR (88% versus 44%, P = .01). Patients with capsulitis had a higher serum creatinine at biopsy (4.6 versus 2.9 mg/dL, P = .04) and were more likely to progress to dialysis (42% versus 13%, P = .06), with fewer recovering their baseline serum creatinine (12% versus 38%, P = .08). Patients with both Banff IA TCMR and capsulitis have clinical outcomes similar to or possibly worse than Banff IB TCMR compared with those with Banff IA and an absence of capsulitis. Capsulitis is an important pathologic parameter in the evaluation of kidney transplant biopsies with potential diagnostic, prognostic, and therapeutic implications in the setting of TCMR.
Keywords: Allograft outcomes; Banff classification; Bowman capsule; Capsulitis; Kidney biopsy; T cell–mediated rejection.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Cell mediated rejection revisited: Past, current, and future directions.Nephrology (Carlton). 2018 Jul;23 Suppl 2:45-51. doi: 10.1111/nep.13283. Nephrology (Carlton). 2018. PMID: 29968416 Review.
-
Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.Nefrologia. 2003 Nov-Dec;23(6):538-44. Nefrologia. 2003. PMID: 15002789
-
Limitations of biopsy-based transcript diagnostics to detect T-cell-mediated allograft rejection.Nephrol Dial Transplant. 2025 Feb 4;40(2):294-307. doi: 10.1093/ndt/gfae147. Nephrol Dial Transplant. 2025. PMID: 38925651 Free PMC article.
-
T-cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel.Clin Transplant. 2024 Jul;38(7):e15410. doi: 10.1111/ctr.15410. Clin Transplant. 2024. PMID: 39033507
-
Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection.Nephrology (Carlton). 2015 Jul;20 Suppl 2:9-15. doi: 10.1111/nep.12460. Nephrology (Carlton). 2015. PMID: 26031579 Review.
Cited by
-
Diagnosis of renal transplant rejection: Banff classification and beyond.Kidney Res Clin Pract. 2020 Mar 31;39(1):17-31. doi: 10.23876/j.krcp.20.003. Kidney Res Clin Pract. 2020. PMID: 32164120 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical